Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
2(20%)
Results Posted
0%(0 trials)
Terminated
1(10%)

Phase Distribution

Ph not_applicable
9
90%
Ph phase_3
1
10%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 3Large-scale testing
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(4)
Terminated(1)
Other(3)

Detailed Status

Completed4
unknown3
Recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (10.0%)
N/A9 (90.0%)

Trials by Status

recruiting220%
completed440%
terminated110%
unknown330%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
10